SYNTHESIS, CHARACTERIZATION, AND OPTIMIZATION OF BIODEGRADABLE PCL-PEG-PCL TRIBLOCK COPOLIMERIC MICELLES AS NANOCARRIERS FOR HYDROPHOBIC DRUG SOLUBILITY ENHANCER
DOI:
https://doi.org/10.22159/ijcpr.2020v12i2.37478Keywords:
Optimization, Triblock copolymers, PCL, PEG, KetoprofenAbstract
Objective: This study aims to synthesize, characterize, and optimize biodegradable polycaprolactone-polyethylene glycol-polycaprolactone (PCL-PEG-PCL) triblock copolimeric micelles as a nanocarrier for hydrophobic drug solubility enhancer of ketoprofen (K).
Methods: PCL-PEG-PCL (PCEC) triblock copolymers was obtained from the synthesis of ɛ-caprolactone (ɛ-CL) and PEG by ring opening polymerization (ROP) method at different PCL: PEG ratio (2-5:1). The K-loaded PCEC triblock copolymeric micelles was obtained by solvent evaporation method. Optimization of PCEC triblock copolymers and analysis of the effect of PCL: PEG ratio factors on the responses toward particle size (PS), polydispersity index (PdI), and entrapment efficiency (EE), were carried out through the design of experiments (DoE) approach of the 22 full factorial design method using the Design-Expert software to obtain the optimum formula.
Results: The higher the PCL: PEG ratio, the ZP value tends to be smaller while the PS, PdI, EE, and drug solubility may be increased, but the addition of hydrophobic blocks to some extent does not affect the EE and drug solubility. The optimum K-loaded PCEC triblock copolymeric micelles with a PCL: PEG 2.0:1 ratio has a zeta potential (ZP) of-24.07±0.35 mV, the particle size of 235.70±6.03 nm, polydispersity index of 0.30±0.06, entrapment efficiency of 87.08±0.06%, and the solubility of the K increases by 10.60 times.
Conclusion: The 22full factorial design has been proven to be the suitable optimization method to determine the optimum condition that yields to the optimum results of the PS, PdI, and EE of the of the K-loaded PCEC triblock copolymer micelles.
Downloads
References
2. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London, Chicago: APhA, (PhP) Pharmaceutical Press; 2009.
3. Hoang NH, Lim C, Sim T, Oh KT. Triblock copolymers for nano-sized drug delivery systems. J Pharm Investigation 2017;47:27–35.
4. Sweetman SC. Martindale: The complete drug reference. 36th ed. London: Pharmaceutical Press; 2009.
5. Shohin IE, Kulinich JI, Ramenskaya GV, Vasilenko. Evaluation of in vitro equivalence for drugs containing BCS class II compound ketoprofen. United States: Dissolution Technologies 2011;18:26–29.
6. Xu W, Ling P, Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Delivery 2013;2013:1–15.
7. Azouz L, Dahmoune F, Rezgui F, G’Sell C. Full factorial design optimization of anti-inflammatory drug release by PCL–PEG–PCL microspheres. Mater Sci Eng Carbon 2016;58:412–9.
8. Hu C, Chen Z, Wu S, Han Y, Wang H, Sun H, et al. Micelle or polymersome formation by pcl-peg-pcl copolymers as drug delivery systems. Chin Chem Lett 2017;28:1905–9.
9. Bolton S, Bon C. Pharmaceutical statistics: practical and clinical aplications. 5th ed. New York: Informa Healthcare USA; 2010.
10. Cavazzuti M. Design of experiments. In: Optimization Methods. Berlin, Heidelberg: Springer; 2013. p. 13–42.
11. Montgomery DC. Design and analysis of experiments. 5th ed. John Wiley and Sons; 2017.
12. Alami Milani M, Zakeri Milani P, Valizadeh H, Salehi R, Jelvehgari M. Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone. Iranian J Basic Med Sci 2018;21:153–64.
13. Hadisoewignyo L, Fudholi A. Sediaan solida edisi revisi. 2nd ed. Yogyakarta: Pustaka Pelajar; 2016.
14. Eatemadi A, Daraee H, Aiyelabegan HT, Negahdari B, Rajeian B, Zarghami. Synthesis and characterization of chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. Biomed Pharmacother 2016;84:1915–22.
15. Manjili HK, Sharafi A, Danafar H, Hosseini M, Ramazani A, Ghasemi MH. Poly(Caprolactone)–Poly(Ethylene Glycol)–Poly(Caprolactone) (PCL–PEG–PCL) nanoparticles: a valuable and efficient system for in vitro and in vivo delivery of curcumin. RSC Adv 2016;6:14403–15.
16. Khodaverdi E, Golmohammadian A, Mohajeri SA, Zohuri G, Mirzazadeh Tekie FS, Hadizadeh F. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive Poly(?-caprolactone)-Poly(ethylene glycol)-Poly(e-caprolactone) Hydrogel. ISRN Pharm 2012;2012:1–7.
17. Cholkar K, Patel A, Vadlapudi AD, Mitra AK. Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery. Recent Pat Nanomed 2012;2:82–95.
18. Lavasanifar A, Samuel J, Sattari S, Kwon GS. Block copolymer micelles for the encapsulation and delivery of amphotericin b. Pharm Res 2002;19:18-422.
19. Cuong NV, Hsieh MF, Chen YT, Liau I. Synthesis and characterization of PEG-PCL-PEG triblock copolymers as carriers of doxorubicin for the treatment of breast cancer. J Appl Polymer Sci 2010;117:3694–703.
20. Danafar H, Rostamizadeh K, Hamidi M. Polylactide/Poly(Ethylene Glycol)/Polylactide triblock copolymer micelles as carrier for delivery of hydrophilic and hydrophobic drugs: a comparison study. J Pharm Invest 2018;48:381–91.
21. Danafar H. Study of the composition of polycaprolactone/Poly (Ethylene Glycol)/Polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles. Jundishapur J Nat Pharm Prod 2016;12:1–9.
22. Danafar H. Preparation and characterization of PCL-PEG-PCL polymersomes for delivery of clavulanic acid. Cogent Med 2016;3:1-11.
23. Ainurofiq A, Choiri S, Azhari MA, Siagian CR, Suryadi BB, Prihapsara F, et al. Improvement of meloxicam solubility using a ?-cyclodextrin complex prepared via the kneading method and incorporated into an orally disintegrating tablet. Adv Pharm Bull 2016;6:399–406.
24. Muhtadi WK, Novitasari L, Martien R, Danarti R. Factorial design as the method in the optimization of timolol maleate-loaded nanoparticle prepared by ionic gelation technique. Int J Appl Pharm 2019;11:66-70.
Published
How to Cite
Issue
Section
